SCHOTT Pharma
Isabel Deister has a diverse work experience in the pharmaceutical industry. Isabel is currently working at SCHOTT Pharma as the Head of Business Development for Glass Syringes. Prior to that, they held the same role at SCHOTT AG, where they focused on the European and Asian markets. Before joining SCHOTT AG, they worked at SCHOTT Schweiz AG as a Business Development Manager for Syringes. Isabel also has experience working at Vetter-Pharma Fertigung GmbH & Co. KG, where they served as a Key Account Manager and a Junior Key Account Manager. Isabel started their career at Vetter Pharma Fertigung GmbH & Co. KG as a Customer Service representative.
Isabel Deister obtained a Diplom degree in BWL (Business Administration) from Berufsakademie Ravensburg, where they studied from 2000 to 2003.
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social